102 related articles for article (PubMed ID: 300403)
1. Neonatal susceptibility to MHV3 infection in mice. I. Transfer of resistance.
Levy-Leblond E; Dupuy JM
J Immunol; 1977 Apr; 118(4):1219-22. PubMed ID: 300403
[TBL] [Abstract][Full Text] [Related]
2. Genetically determined resistance to mouse hepatitis virus 3 is expressed in hematopoietic donor cells in radiation chimeras.
Dupuy JM; Dupuy C; Décarie D
J Immunol; 1984 Sep; 133(3):1609-13. PubMed ID: 6146650
[TBL] [Abstract][Full Text] [Related]
3. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity.
Lamontagne L; Descoteaux JP; Jolicoeur P
J Immunol; 1989 Jun; 142(12):4458-65. PubMed ID: 2542412
[TBL] [Abstract][Full Text] [Related]
4. Neonatal susceptibility to MHV3 infection in mice. II. Role of natural effector marrow cells in transfer of resistance.
Tardieu M; Héry C; Dupuy JM
J Immunol; 1980 Jan; 124(1):418-23. PubMed ID: 6243152
[TBL] [Abstract][Full Text] [Related]
5. Studies on the transfer of protective immunity with lymphoid cells from mice immune to malaria sporozoites.
Verhave JP; Strickland GT; Jaffe HA; Ahmed A
J Immunol; 1978 Sep; 121(3):1031-3. PubMed ID: 99475
[TBL] [Abstract][Full Text] [Related]
6. Cellular cooperation during in vivo anti-hapten antibody responses. III. The helper cell activity of activated thymocytes, of spleen cells treated with anti-theta serum, and of spleen cells from anti-thymocyte serum-treated or adult thymectomized donors.
Janeway CA
J Immunol; 1975 Apr; 114(4):1408-14. PubMed ID: 1078836
[TBL] [Abstract][Full Text] [Related]
7. Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection.
Stohlman SA; Frelinger JA; Weiner LP
J Immunol; 1980 Apr; 124(4):1733-9. PubMed ID: 6245128
[TBL] [Abstract][Full Text] [Related]
8. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
9. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
[TBL] [Abstract][Full Text] [Related]
10. Resistance of genetically selected mice to MHV3 infection is not dependent on the H2O2 release by macrophages.
Vassão R; Russo M; Marcondes MC; Pereira CA
Microb Pathog; 1993 Mar; 14(3):169-76. PubMed ID: 8391622
[TBL] [Abstract][Full Text] [Related]
11. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
Fujimoto S; Greene MI; Sehon AH
J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
[TBL] [Abstract][Full Text] [Related]
12. Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms.
Le Prevost C; Levy-Leblond E; Virelizier JL; Dupuy JM
J Immunol; 1975 Jan; 114(1 Pt 1):221-5. PubMed ID: 163277
[TBL] [Abstract][Full Text] [Related]
13. Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3.
Jolicoeur P; Lamontagne L
J Immunol; 1994 Aug; 153(3):1318-7. PubMed ID: 8027559
[TBL] [Abstract][Full Text] [Related]
14. Immune mechanisms in leukemia: protective capacity of the major lymphoid cell compartments.
Lukasewycz OA; Duffey PS; Murphy WH
J Immunol; 1976 Apr; 116(4):976-81. PubMed ID: 1082909
[TBL] [Abstract][Full Text] [Related]
15. Mouse hepatitis virus 3 pathogenicity expressed by a lytic viral infection in bone marrow 14.8+ mu+ B lymphocyte subpopulations.
Jolicoeur P; Lamontagne L
J Immunol; 1989 Dec; 143(11):3722-30. PubMed ID: 2555417
[TBL] [Abstract][Full Text] [Related]
16. Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses.
Ishizaka K; Adachi T
J Immunol; 1976 Jul; 117(1):40-7. PubMed ID: 1084370
[TBL] [Abstract][Full Text] [Related]
17. Lymphoid cell dependence of eosinophil response to antigen. VI. The effect of selective removal of T or B lymphocytes on the capacity of primed spleen cells to adoptively transferred immunity to tetanus toxoid.
Ponzio NM; Speirs RS
Immunology; 1975 Feb; 28(2):243-51. PubMed ID: 1079015
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine release as measurement of anti-mouse hepatitis virus type 3 (MHV3) cellular reactions in various mouse lines exhibiting differential susceptibilities to MHV3-induced paralysis.
Mansour S; Mercier G; Oth D
Acta Virol; 1990 Sep; 34(5):423-32. PubMed ID: 1981453
[TBL] [Abstract][Full Text] [Related]
19. [Response of splenic lymphocytes to phytohemagglutinin and bacterial lipopolysaccharide in mice, sensitive and resistant to mouse hepatitis virus 3 (MHV3)].
Grollemund E; Obert G; Nonnenmacher H; Kirn A
C R Seances Acad Sci III; 1981 Feb; 292(8):533-6. PubMed ID: 6261984
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of antigen-presenting activity of haptenized cells in mice: early development of syngeneic T cell-stimulatory cells in thymus.
Hosono M; Katsura Y; Muramatsu S
Immunology; 1984 Jan; 51(1):161-8. PubMed ID: 6606616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
